Search

everythinglearnresearchcommunity

for

Search:↓

Combining PRP with follicular transplantation improves vitiligo treatment better than follicular transplantation alone.

A new surgical technique using vellus hair grafts effectively treated vitiligo without causing unwanted hair growth.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Silymarin with hair follicle transplantation might help treat stubborn vitiligo, but more research is needed.

Upadacitinib improved multiple immune-related conditions in one patient.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Phototherapy is effective in treating vitiligo.

New treatments for vitiligo show promise but still face challenges, especially for hands and feet.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Combining hair transplantation with microneedling or laser and UV light may help treat tough vitiligo on hands and feet, with microneedling being affordable and easy to learn.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Rituximab can cause skin issues, but baricitinib may help improve them.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Hair follicle-derived sheets can effectively treat vitiligo by repigmenting skin.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Punch grafting treats vitiligo faster but can cause a cobblestone look, while follicular hair transplantation is slower but looks better and has no side effects.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Certain drugs may cause vitiligo, so patients should be monitored.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Surgical therapies for vitiligo vary in effectiveness, with combination therapy and medical tattooing recommended for better results.

PRP combined with vitamin D improves vitiligo more effectively than vitamin D alone.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.